Comparison between the oral and intravenous L-[1-13C]phenylalanine breath test for the assessment of liver function

Isotopes in Environmental and Health Studies

Volumn 35, Issue 3, 1999, Pages 147-156

  Tugtekin, I ^a,b   Radermacher, P ^a   Wachter, U ^a   Barth, E ^a   Weidenbach, H ^a   Adler, G ^a   Georgieff, M ^a   Vogt, J ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Breath test; Carbon 13; Cirrhosis; IRMS; Liver function; Phenylalanine

Indexed keywords

CARBON; PHENYLALANINE;

ARTICLE; BREATH ANALYSIS; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY;

ADMINISTRATION, ORAL; BREATH TESTS; CARBON ISOTOPES; CASE-CONTROL STUDIES; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PHENYLALANINE;

EID: 0033291199     PISSN: 10256016     EISSN: None     Source Type: Journal    
DOI: 10.1080/10256019908234090     Document Type: Article

References (15)

1. Barstow, L. and Small, R. E. (1990). Liver assessment by drug metabolism. Pharmacother, 10, 280-288.
2. Reichen, J. (1995). Assessment of hepatic function with xenobiotics. Sem. Liver Dis., 15, 189-201.
3. Sallie, R., Tredger, M. and Williams, R. (1991). Drugs and the liver - part 1: testing liver function. Biochem. Drug Dis., 12, 251-259.
4. Merkel, C., Bolognesi, M., Bellon, S., Bianco, S., Honisch, B., Lampe, H., Angeli, P. and Gatta, A. (1992). Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut, 33, 836-842.
5. Baker, A. L., Kotake, A. N. and Schoeller, D. A. (1983). Clinical utility of breath tests for the assessment of hepatic function. Sem. Liver Dis., 3, 318-329.
6. Scriver, C. R., Kaufman, S. and Woo, S. L. C., The hyperphenylalaninemias. In: The Metabolic Basis of Inherited Disease, Scriver, C. R., Beaudet, A. L., Sly, W. S. and Valle, D. (Eds.), McGraw-Hill, New York 1989, pp. 495-546.
7. Fish, M. B., Pollycove, M., DeGrazia, J., Cohen, P. and Fleury, K. (1968). Effect of route and load of administered phenylalanine on human in vivo phenylalanine catabolism. J. Nucl. Med., 9, 317.
8. 13C]Phenylalanine oxidation as a measure of hepatocyte functional capacity in end stage liver disease. Am. J. Surg., 173, 270-273.
9. Chang, W. K., Chao, Y. C., Tang, H. S., Lang, H. F. and Hsu, C. T. (1997). Effects of extra-carbohydrate supplementation in the late evening on energy expenditure and substrate oxidation in patients with liver cirrhosis. J. Parenter. Enter. Nutr., 21, 96-99.
10. 2. Gastroenterology, 71, 98-101.
11. Schoeller, D. A., Baker, A. L., Monoroe, P. S., Krager, P. S. and Schneider, J. F. (1982). Comparison of different methods of expressing results of the aminopyrine breath test. Hepatology, 2, 455-462.
12. Lane, E. A. and Parashos, I. (1986). Drug pharmacokinetics and the carbon dioxide breath test. J. Pharmacokinet. Biopharm, 14, 29-49.
13. Matthews, D. E., Marano, M. A. and Campbell, R. G. (1993). Splanchnic bed utilization of leucine and phenylalanine in humans. Am. J. Physiol., pp. E109-E118.
14. Tessari, P., Inchiostro, S., Barazzoni, R., Zanetti, M., Orlando, R., Biolo, G., Sergi, G. and Pino, A. (1994). Fasting and postprandial phenylalanine and leucine kinetics in liver cirrhosis. Am. J. Physiol., 267, E140-E149.
15. 13C]phenylalanine oxidation rates in vivo: a pilot study. Pediatr. Res., 42, 430-435.